Skip to content

Construction and empirical research on resistance training regimens for breast cancer-related lymphedema

Construction and empirical research on resistance training regimens for breast cancer-related lymphedema

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049217
Enrollment
Unknown
Registered
2021-07-25
Start date
2021-08-10
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

control group:Basic treatment of breast cancer-related lymphedema
intervention group:Basic treatment and resistance training of breast cancer-related lymphedema

Sponsors

School of Nursing, Peking University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Axillary lymphadenectomy for breast cancer, patients with unilateral limb lymphedema; 2. In the stable stage of lymphedema (no intensive treatment of lymphedema (ie, decongestant therapy or antibiotic treatment for infection) in the past three months, the change in the circumference of the upper limbs is less than 10%, and the activities of daily living have not changed); 3. Aged 25-65 years; 4. Clear consciousness, no language communication barriers, and certain reading and communication skills; 5. Edema limbs can move independently; 6. There is no physical condition or drug contraindication that would prohibit participation in muscle strength testing and resistance training; 7. No self-reported participation in resistance exercise or aerobic exercise more than 3 times per week in the past 12 months; 8. Informed consent, voluntary participation in this research.

Exclusion criteria

Exclusion criteria: 1. Unfinished breast cancer related treatment; 2. Patients with breast cancer metastasis; 3. Previous swelling of the arm due to other reasons (trauma, allergy, etc.); 4. Patients with heart and kidney disease, deep vein thrombosis; 5. Nervous system diseases; 6. Acute inflammation; 7. Those who have a surgical plan during the study period; 8. Severe anemia, extreme fatigue or ataxia; 9. Osteoporosis, high risk of fracture; 10. Ostomy patients.

Design outcomes

Primary

MeasureTime frame
muscle strength;edema degree;edema-related symptoms;

Secondary

MeasureTime frame
quality of life;

Countries

China

Contacts

Public ContactShang Shaomei

School of Nursing, Peking University

mei916@263.net+86 13911091935

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026